Order Article Reprints

Yoon J-H, Kim S-E, Cho S-H, Kim G-A, Park Y, Park J-W, Kang S-H, Lee Y-S, Kim J-H. Prognosis of Patients with Chronic Hepatitis C Genotype 1b Infection Treated Using Daclatasvir/Asunaprevir after Sustained Virologic Response: A 6-Year Multicenter Prospective Observational Study. Medicina. 2023; 59(8):1436. https://doi.org/10.3390/medicina59081436

Yoon, Jae-Hyun, Sung-Eun Kim, Su-Hyeon Cho, Gi-Ae Kim, Yewan Park, Ji-Won Park, Seong-Hee Kang, Young-Sun Lee, and Jeong-Han Kim. 2023. "Prognosis of Patients with Chronic Hepatitis C Genotype 1b Infection Treated Using Daclatasvir/Asunaprevir after Sustained Virologic Response: A 6-Year Multicenter Prospective Observational Study" Medicina 59, no. 8: 1436. https://doi.org/10.3390/medicina59081436

Yoon, J.-H., Kim, S.-E., Cho, S.-H., Kim, G.-A., Park, Y., Park, J.-W., Kang, S.-H., Lee, Y.-S., & Kim, J.-H. (2023). Prognosis of Patients with Chronic Hepatitis C Genotype 1b Infection Treated Using Daclatasvir/Asunaprevir after Sustained Virologic Response: A 6-Year Multicenter Prospective Observational Study. Medicina, 59(8), 1436. https://doi.org/10.3390/medicina59081436